The Orasure Technologies Inc. subsidiary, which is based in Ottawa, announced a grant program Tuesday with the winning research proposal receiving US$30,000 and up to 500 sample collection kits.
The grant program's three areas are cancer, personalized medicine and infectious disease.
"We want to reward those who are pushing the boundaries of what can be done with DNA or RNA while contributing to the scientific idea pipeline for cancer, personalized medicine or infectious disease research," stated president Ian Curry.
Applications are due Jan. 16 and the winner will be notified in March.
DNA Genotek was acquired for US$53 million earlier this year, and expects to grow its employee numbers – it then had 70 – after the acquisition.
The company was one of OBJ's Fastest-Growing Companies in 2010 with three-year revenue growth of 153 per cent.
DNA Genotek was founded in 1998 and does saliva collection for DNA testing, which it says is a less invasive way than the traditional blood tests. Its parent company Orasure develops, manufactures and markets oral fluid specimen devices, focusing on infectious diseases such as HIV.